A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa

Iwuji, Collins, Pillay, Diantha, Shamu, Patience, Murire, Mercy, NZENZE, Susan, Cox, Laura Ashleigh and Mullick, Saiqa (2022) A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa. Journal of Antimicrobial Chemotherapy, 77 (8). pp. 2074-2093. ISSN 0305-7453

[img] PDF - Accepted Version
Restricted to SRO admin only

Download (497kB)
[img] PDF (Table S1) - Supplemental Material
Restricted to SRO admin only

Download (175kB)
[img] PDF - Published Version
Available under License Creative Commons Attribution-Non-Commercial.

Download (590kB)

Abstract

Introduction
Limited antimicrobial resistance (AMR) surveillance coupled with syndromic management of sexually transmitted infections (STIs) in sub-Saharan Africa (SSA) could be contributing to an increase in AMR in the region. This systematic review aims to synthesise data on the prevalence of AMR in common STIs in SSA and identify some research gaps that exist.

Methods
We searched three electronic databases for studies published between 1 January 2000 and 26 May 2020. We screened the titles and abstracts for studies that potentially contained data on AMR in SSA. Then we reviewed the full text of these studies to identify articles that reported data on the prevalence of AMR in Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), Trichomonas vaginalis (TV) and Mycoplasma genitalium (MG) in SSA. We summarised the data using a narrative synthesis.

Results
The 40 included studies reported on AMR data from 7961 NG isolates from 15 countries in SSA and 350 MG specimens from South Africa. All four SSA regions reported very high rates of ciprofloxacin, tetracycline and penicillin resistance in NG. Resistance to cefixime or ceftriaxone was observed in all regions except West Africa. Azithromycin resistance, recommended as part of dual therapy with the ESC for gonorrhoea, was reported in all the regions. Both macrolide and fluoroquinolone-associated resistance were reported in MG in South Africa. Studies investigating AMR in CT and TV were not identified.

Conclusion
There is a need to strengthen AMR surveillance in SSA for prompt investigation and notification of drug resistance in STIs.

Item Type: Article
Schools and Departments: Brighton and Sussex Medical School > Global Health and Infection
SWORD Depositor: Mx Elements Account
Depositing User: Mx Elements Account
Date Deposited: 26 Apr 2022 08:28
Last Modified: 15 Aug 2022 10:15
URI: http://sro.sussex.ac.uk/id/eprint/105512

View download statistics for this item

📧 Request an update